Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 28, 2015; 21(24): 7545-7552
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7545
Table 3 Summarizing univariate and multivariate analyses of the study
CD
GS
UnivariateMultivariateUnivariateMultivariate
AgeNSNSNSNS
SexNSNSNSNS
IELs count-IELs > 25-IELs > 25-IELs > 25 NS-IELs > 25 NS
OR = 30.5; 95%CI: 6.994-132.8; P < 0.0001OR = 1640.4; 95%CI: 104.7-2341.1; P = 0.004-IELs 15-25-IELs 15-25
-IELs 15-25-IELs 15-25
OR = 2.5 95%CI: 1.16-3.95; P = 0.02OR = 16.95; 95%CI: 4.9-61.2; P = 0.01OR = 8.76; 95%CI: 4.31-21.45; P = 0.01OR = 28.59; 95%CI: 10.12-57.26; P = 0.009
Familiarity for CDOR = 18.48; 95%CI: 2.161-1016; P = 0.007NSNSNS
IgG - anti-gliadin antibodiesNSNSNSNS
Autoimmune thyroiditisNSNSNSOR = 87.63; 95%CI: 28.16-129.93; P = 0.017
Iron deficiency anemiaNSNSNSNS
Folate deficiencyNSNSOR = 3.48; 95%CI: 1.78-12.32; P = 0.04OR = 48.53; 95%CI: 26.73-76.12; P = 0.01
DQ 2-8OR = 11.58; 95%CI: 3.399-39.43; P < 0.0001OR = 140.85; 95%CI: 4.9-678.84; P = 0.012NSNS
DQA1*0501 heterozygosisNSOR = 15.36; 95%CI: 2.11-47.32; P = 0.02NSNS
Weight lossNSNSNSNS
Abdominal painNSNSNSNS
DiarrheaOR = 10.45; 95%CI: 3.221-33.88; P < 0.0001OR = 5.56; 95%CI: 3.55-12.45; P = 0.02OR = 5.571; 95%CI: 1.567-19.80; P = 0.01OR = 54.87; 95%CI: 46.12-71.36; P = 0.008
WeaknessOR = 5.0; 95%CI: 1.519-16.46; P = 0.01OR = 11.57; 95%CI: 6.61-18.34; P = 0.017NSNS
HeadacheNSNSNSNS